North Dallas Research Associates

McKinney, Texas 75609

4 studies enrolling now · 27 studies all time

What they study most

ASCVD, Arterial Dissection, Artery Disease, Peripheral, Artery Diseases, Peripheral, Atherosclerosis, Atrial Fibrillation, Atrial Flutter, Cardiovascular Disease, Chronic Venous Insufficiency, Coronary Artery Disease, Critical Limb Ischemia, Deep Vein Thrombosis

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) — Recruiting now
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes — Recruiting now
• Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes — Recruiting now
• The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study — Completed
• MOTIV BTK Randomized Controlled Trial — Running, not enrolling
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial — Completed
• Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System — Completed
• Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression — Completed
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
• Safety and Efficacy of the SurVeil™ Drug-Coated Balloon — Completed
• A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Stopped early
• RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty — Completed
• Tack Optimized Balloon Angioplasty Post-Market Study — Stopped early
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• MIMICS-3D-USA Registry Study — Status unconfirmed
• Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF — Completed
• Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries — Completed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries — Completed
• The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed